Can ruxolitinib/ruxolitinib cream completely cure vitiligo?

Vitiligo is a common pigmented skin disease characterized by white patches of varying sizes on the skin, usually caused by damage or death of melanocytes in the skin. The causes are complex, including immune system abnormalities, genetic factors, and environmental stimuli. In recent years, with the development of immunosuppressive therapy, especially the introduction of JAK inhibitor drugs, new breakthroughs have been made in the treatment of vitiligo. Ruxolitinib/ruxolitinib cream As a topically applied JAK inhibitor drug, it has shown certain efficacy in the clinical treatment of vitiligo.

Ruxolitinib cream is a topicalJAK inhibitor. Its mechanism of action is to reduce the immune system's attack on skin melanocytes by inhibiting the JAK-STAT signaling pathway. The JAK-STAT pathway plays an important role in the immune response and inflammatory process, and the occurrence of vitiligo is closely related to immune system abnormalities, especially T cells attacking melanocytes. Ruxolitinib reduces the immune system's damage to skin pigment cells by locally inhibiting this signaling pathway, thereby promoting the recovery of local melanin.

Clinical studies have shown that ruxolitinib cream has good efficacy in patients with mild to moderate vitiligo. In some studies, about 50% of patients experienced significant pigment recovery after several months of treatment, especially in areas with more active skin metabolism such as the face and neck. Ruxolitinib cream can effectively stimulate the production of melanin and slow down the attack process of immune cells on the skin through local action, thereby gradually improving the symptoms of vitiligo.

However, although ruxolitinib cream has made some progress in improving skin pigment recovery, it has not shown the ability to "completely cure" vitiligo. The cure standard for vitiligo is not only the restoration of the pigment to its original state, but also the stability of the immune system and long-term effects. Although ruxolitinib cream can help control localized symptoms of vitiligo, it does not completely cure the cause or guarantee that the condition will not return.

Reference: https://www.opzelura.com/